Cargando…

Pancreatic neuroendocrine tumor Grade 1 patients followed up without surgery: Case series

Among the three grades of neuroendocrine tumors (NETs), the prognosis for Grade 1 (G1) with surgery is very good. Therefore, we evaluated the prognoses of pancreatic NET (PNET) G1 patients without surgery. A total of 8 patients who were diagnosed with NET G1, with an observation period of more than...

Descripción completa

Detalles Bibliográficos
Autores principales: Sugimoto, Mitsuru, Takagi, Tadayuki, Suzuki, Rei, Konno, Naoki, Asama, Hiroyuki, Watanabe, Ko, Nakamura, Jun, Kikuchi, Hitomi, Waragai, Yuichi, Takasumi, Mika, Kawana, Satoshi, Hashimoto, Yuko, Hikichi, Takuto, Ohira, Hiromasa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5465021/
https://www.ncbi.nlm.nih.gov/pubmed/28638801
http://dx.doi.org/10.5306/wjco.v8.i3.293
_version_ 1783242874552320000
author Sugimoto, Mitsuru
Takagi, Tadayuki
Suzuki, Rei
Konno, Naoki
Asama, Hiroyuki
Watanabe, Ko
Nakamura, Jun
Kikuchi, Hitomi
Waragai, Yuichi
Takasumi, Mika
Kawana, Satoshi
Hashimoto, Yuko
Hikichi, Takuto
Ohira, Hiromasa
author_facet Sugimoto, Mitsuru
Takagi, Tadayuki
Suzuki, Rei
Konno, Naoki
Asama, Hiroyuki
Watanabe, Ko
Nakamura, Jun
Kikuchi, Hitomi
Waragai, Yuichi
Takasumi, Mika
Kawana, Satoshi
Hashimoto, Yuko
Hikichi, Takuto
Ohira, Hiromasa
author_sort Sugimoto, Mitsuru
collection PubMed
description Among the three grades of neuroendocrine tumors (NETs), the prognosis for Grade 1 (G1) with surgery is very good. Therefore, we evaluated the prognoses of pancreatic NET (PNET) G1 patients without surgery. A total of 8 patients who were diagnosed with NET G1, with an observation period of more than 6 mo until surgery or without surgery, were recruited. The patients who underwent surgery were ultimately diagnosed using specimens obtained during the surgery, whereas the patients who did not undergo surgery were diagnosed using specimens obtained by endoscopic ultrasonography-guided fine needle aspiration. Overall, we mainly evaluated the observation period and tumor growth. The observation period for the five cases with surgery ranged from 6-80 mo, and tumor growth was observed in one case. In contrast, the observation period for the three cases without surgery ranged from 17-54 mo, and tumor growth was not observed. Therefore, although the first-choice treatment for NETs is surgery, our experience includes certain NET G1 patients who were followed up without surgery.
format Online
Article
Text
id pubmed-5465021
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Baishideng Publishing Group Inc
record_format MEDLINE/PubMed
spelling pubmed-54650212017-06-22 Pancreatic neuroendocrine tumor Grade 1 patients followed up without surgery: Case series Sugimoto, Mitsuru Takagi, Tadayuki Suzuki, Rei Konno, Naoki Asama, Hiroyuki Watanabe, Ko Nakamura, Jun Kikuchi, Hitomi Waragai, Yuichi Takasumi, Mika Kawana, Satoshi Hashimoto, Yuko Hikichi, Takuto Ohira, Hiromasa World J Clin Oncol Case Report Among the three grades of neuroendocrine tumors (NETs), the prognosis for Grade 1 (G1) with surgery is very good. Therefore, we evaluated the prognoses of pancreatic NET (PNET) G1 patients without surgery. A total of 8 patients who were diagnosed with NET G1, with an observation period of more than 6 mo until surgery or without surgery, were recruited. The patients who underwent surgery were ultimately diagnosed using specimens obtained during the surgery, whereas the patients who did not undergo surgery were diagnosed using specimens obtained by endoscopic ultrasonography-guided fine needle aspiration. Overall, we mainly evaluated the observation period and tumor growth. The observation period for the five cases with surgery ranged from 6-80 mo, and tumor growth was observed in one case. In contrast, the observation period for the three cases without surgery ranged from 17-54 mo, and tumor growth was not observed. Therefore, although the first-choice treatment for NETs is surgery, our experience includes certain NET G1 patients who were followed up without surgery. Baishideng Publishing Group Inc 2017-06-10 2017-06-10 /pmc/articles/PMC5465021/ /pubmed/28638801 http://dx.doi.org/10.5306/wjco.v8.i3.293 Text en ©The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved. http://creativecommons.org/licenses/by-nc/4.0/ Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
spellingShingle Case Report
Sugimoto, Mitsuru
Takagi, Tadayuki
Suzuki, Rei
Konno, Naoki
Asama, Hiroyuki
Watanabe, Ko
Nakamura, Jun
Kikuchi, Hitomi
Waragai, Yuichi
Takasumi, Mika
Kawana, Satoshi
Hashimoto, Yuko
Hikichi, Takuto
Ohira, Hiromasa
Pancreatic neuroendocrine tumor Grade 1 patients followed up without surgery: Case series
title Pancreatic neuroendocrine tumor Grade 1 patients followed up without surgery: Case series
title_full Pancreatic neuroendocrine tumor Grade 1 patients followed up without surgery: Case series
title_fullStr Pancreatic neuroendocrine tumor Grade 1 patients followed up without surgery: Case series
title_full_unstemmed Pancreatic neuroendocrine tumor Grade 1 patients followed up without surgery: Case series
title_short Pancreatic neuroendocrine tumor Grade 1 patients followed up without surgery: Case series
title_sort pancreatic neuroendocrine tumor grade 1 patients followed up without surgery: case series
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5465021/
https://www.ncbi.nlm.nih.gov/pubmed/28638801
http://dx.doi.org/10.5306/wjco.v8.i3.293
work_keys_str_mv AT sugimotomitsuru pancreaticneuroendocrinetumorgrade1patientsfollowedupwithoutsurgerycaseseries
AT takagitadayuki pancreaticneuroendocrinetumorgrade1patientsfollowedupwithoutsurgerycaseseries
AT suzukirei pancreaticneuroendocrinetumorgrade1patientsfollowedupwithoutsurgerycaseseries
AT konnonaoki pancreaticneuroendocrinetumorgrade1patientsfollowedupwithoutsurgerycaseseries
AT asamahiroyuki pancreaticneuroendocrinetumorgrade1patientsfollowedupwithoutsurgerycaseseries
AT watanabeko pancreaticneuroendocrinetumorgrade1patientsfollowedupwithoutsurgerycaseseries
AT nakamurajun pancreaticneuroendocrinetumorgrade1patientsfollowedupwithoutsurgerycaseseries
AT kikuchihitomi pancreaticneuroendocrinetumorgrade1patientsfollowedupwithoutsurgerycaseseries
AT waragaiyuichi pancreaticneuroendocrinetumorgrade1patientsfollowedupwithoutsurgerycaseseries
AT takasumimika pancreaticneuroendocrinetumorgrade1patientsfollowedupwithoutsurgerycaseseries
AT kawanasatoshi pancreaticneuroendocrinetumorgrade1patientsfollowedupwithoutsurgerycaseseries
AT hashimotoyuko pancreaticneuroendocrinetumorgrade1patientsfollowedupwithoutsurgerycaseseries
AT hikichitakuto pancreaticneuroendocrinetumorgrade1patientsfollowedupwithoutsurgerycaseseries
AT ohirahiromasa pancreaticneuroendocrinetumorgrade1patientsfollowedupwithoutsurgerycaseseries